These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans. Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648 [TBL] [Abstract][Full Text] [Related]
3. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. Marchi N; Fazio V; Cucullo L; Kight K; Masaryk T; Barnett G; Vogelbaum M; Kinter M; Rasmussen P; Mayberg MR; Janigro D J Neurosci; 2003 Mar; 23(5):1949-55. PubMed ID: 12629200 [TBL] [Abstract][Full Text] [Related]
4. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery. Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413 [TBL] [Abstract][Full Text] [Related]
5. [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]. Heimberger K; Samec P; Podreka I; Binder H; Suess E; Reisner T; Deecke L; Steger G; Hiesmayr M; Dittrich C Wien Klin Wochenschr; 1987 May; 99(11):385-8. PubMed ID: 3113082 [TBL] [Abstract][Full Text] [Related]
6. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378 [TBL] [Abstract][Full Text] [Related]
7. Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity. Marchi N; Teng Q; Nguyen MT; Franic L; Desai NK; Masaryk T; Rasmussen P; Trasciatti S; Janigro D BMC Neurosci; 2010 Mar; 11():34. PubMed ID: 20214812 [TBL] [Abstract][Full Text] [Related]
8. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316 [TBL] [Abstract][Full Text] [Related]
9. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence. Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039 [TBL] [Abstract][Full Text] [Related]
14. Osmotic blood-brain barrier modification for the treatment of malignant brain tumors. Haluska M; Anthony ML Clin J Oncol Nurs; 2004 Jun; 8(3):263-7. PubMed ID: 15208820 [TBL] [Abstract][Full Text] [Related]
15. The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts. Remsen LG; Pagel MA; McCormick CI; Fiamengo SA; Sexton G; Neuwelt EA Anesth Analg; 1999 Mar; 88(3):559-67. PubMed ID: 10072006 [TBL] [Abstract][Full Text] [Related]
16. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma. Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Marchi N; Teng Q; Ghosh C; Fan Q; Nguyen MT; Desai NK; Bawa H; Rasmussen P; Masaryk TK; Janigro D Brain Res; 2010 Sep; 1353():176-86. PubMed ID: 20599815 [TBL] [Abstract][Full Text] [Related]